Published in J Virol on August 01, 1991
Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus. J Virol (1995) 3.18
Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc Natl Acad Sci U S A (2002) 2.94
Gene expression during reactivation of herpes simplex virus type 1 from latency in the peripheral nervous system is different from that during lytic infection of tissue cultures. J Virol (1997) 1.86
Nuclear localization of the C1 factor (host cell factor) in sensory neurons correlates with reactivation of herpes simplex virus from latency. Proc Natl Acad Sci U S A (1999) 1.64
The latency-related gene of bovine herpesvirus 1 encodes a product which inhibits cell cycle progression. J Virol (1996) 1.33
Intact TRL 9 and type I interferon signaling pathways are required to augment HSV-1 induced corneal CXCL9 and CXCL10. J Neuroimmunol (2006) 1.18
Herpes simplex virus type 1 latently infected neurons differentially express latency-associated and ICP0 transcripts. J Virol (2006) 1.17
The molecular basis of herpes simplex virus latency. FEMS Microbiol Rev (2012) 1.12
Herpes simplex virus type 1 mutant strain in1814 establishes a unique, slowly progressing infection in SCID mice. J Virol (1992) 1.05
Herpes simplex virus infections are arrested in Oct-1-deficient cells. Proc Natl Acad Sci U S A (2004) 1.01
The PK domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is required for immediate-early gene expression and virus growth. J Virol (1998) 0.99
Induction of reactivation of herpes simplex virus in murine sensory ganglia in vivo by cadmium. J Virol (1993) 0.99
Transcription factors interacting with herpes simplex virus alpha gene promoters in sensory neurons. Nucleic Acids Res (1995) 0.99
Neurons differentially activate the herpes simplex virus type 1 immediate-early gene ICP0 and ICP27 promoters in transgenic mice. J Virol (2002) 0.97
Herpes simplex virus type 2 vaccines: new ground for optimism? Clin Diagn Lab Immunol (2004) 0.94
Neurons differentially control expression of a herpes simplex virus type 1 immediate-early promoter in transgenic mice. J Virol (1995) 0.93
Role of chromatin during herpesvirus infections. Biochim Biophys Acta (2009) 0.91
Herpes latency, meningitis, radiculomyelopathy and disseminated infection. Genitourin Med (1994) 0.87
Mutually exclusive binding of two cellular factors within a critical promoter region of the gene for the IE110k protein of herpes simplex virus. J Virol (1993) 0.87
Role of tumor invasiveness, the extracellular matrix, and chromatin sequestration in the susceptibility of uveal melanoma to herpes simplex virus type 1. Exp Eye Res (2007) 0.82
HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis. Neoplasia (1999) 0.81
B7 costimulation molecules encoded by replication-defective, vhs-deficient HSV-1 improve vaccine-induced protection against corneal disease. PLoS One (2011) 0.81
Nectin-1-specific entry of herpes simplex virus 1 is sufficient for infection of the cornea and viral spread to the trigeminal ganglia. Mol Vis (2012) 0.80
Prior Corneal Scarification and Injection of Immune Serum are Not Required Before Ocular HSV-1 Infection for UV-B-Induced Virus Reactivation and Recurrent Herpetic Corneal Disease in Latently Infected Mice. Curr Eye Res (2015) 0.79
Control of herpes simplex virus type 1 mRNA synthesis in cells infected with wild-type virus or the temperature-sensitive mutant tsK. J Virol (1979) 11.34
RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science (1987) 11.14
The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain. Genes Dev (1988) 8.11
Latent herpes simplex virus in spinal ganglia of mice. Science (1971) 7.04
Cloning of reiterated and nonreiterated herpes simplex virus 1 sequences as BamHI fragments. Proc Natl Acad Sci U S A (1980) 6.66
FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA. J Virol (1982) 6.11
Expression of a large family of POU-domain regulatory genes in mammalian brain development. Nature (1989) 5.68
Recovery of herpes-simplex virus from human trigeminal ganglions. N Engl J Med (1973) 5.66
The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron (1990) 5.19
Herpes simplex virus regulatory elements and the immunoglobulin octamer domain bind a common factor and are both targets for virion transactivation. Cell (1988) 5.18
Detection of herpes simplex virus type 1 transcripts during latent infection in mice. J Virol (1987) 5.12
RNA from an immediate early region of the type 1 herpes simplex virus genome is present in the trigeminal ganglia of latently infected mice. Proc Natl Acad Sci U S A (1987) 4.98
A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency. J Virol (1989) 4.85
Herpes simplex virus latent phase transcription facilitates in vivo reactivation. Virology (1990) 4.00
Sp1 binds to promoter sequences and activates herpes simplex virus 'immediate-early' gene transcription in vitro. Nature (1985) 3.99
Fos and Jun bind cooperatively to the AP-1 site: reconstitution in vitro. Genes Dev (1988) 3.70
Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infection. EMBO J (1989) 3.65
The octamer-binding proteins form multi-protein--DNA complexes with the HSV alpha TIF regulatory protein. EMBO J (1989) 3.42
An inquiry into the mechanisms of herpes simplex virus latency. Annu Rev Microbiol (1987) 3.39
Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc Natl Acad Sci U S A (1989) 3.26
Human beta-nerve growth factor gene sequence highly homologous to that of mouse. Nature (1983) 3.17
Human herpesviruses: a consideration of the latent state. Microbiol Rev (1989) 3.15
Expression of herpes simplex virus type 1 latency-associated transcripts in the trigeminal ganglia of mice during acute infection and reactivation of latent infection. J Virol (1988) 2.80
The human mid-size neurofilament subunit: a repeated protein sequence and the relationship of its gene to the intermediate filament gene family. EMBO J (1987) 2.72
Isolation of latent herpes simplex virus from the superior cervical and vagus ganglions of human beings. N Engl J Med (1978) 2.55
Latent herpes simplex virus type 1 transcripts in peripheral and central nervous system tissues of mice map to similar regions of the viral genome. J Virol (1988) 2.46
Neurofilament gene expression: a major determinant of axonal caliber. Proc Natl Acad Sci U S A (1987) 2.36
Characterization of a major late herpes simplex virus type 1 mRNA. J Virol (1981) 2.29
Activation of cellular stress protein genes by herpes simplex virus temperature-sensitive mutants which overproduce immediate early polypeptides. Virology (1982) 2.03
Nerve growth factor deprivation results in the reactivation of latent herpes simplex virus in vitro. J Virol (1987) 2.01
Pathogenesis of herpetic encephalitis in mice after ophthalmic inoculation. J Infect Dis (1974) 1.80
Timing and site of nerve growth factor synthesis in developing skin in relation to innervation and expression of the receptor. Nature (1987) 1.76
Relationship between levels of nerve growth factor (NGF) and its messenger RNA in sympathetic ganglia and peripheral target tissues. EMBO J (1984) 1.71
Strain specificity of spontaneous and adrenergically induced HSV-1 ocular reactivation in latently infected rabbits. Curr Eye Res (1987) 1.70
Experimental herpes simplex encephalitis: early neuropathologic changes. J Neuropathol Exp Neurol (1970) 1.65
Herpes simplex virus Vmw65-octamer binding protein interaction: a paradigm for combinatorial control of transcription. Virology (1989) 1.65
Octamer motif mediates transcriptional repression of HSV immediate-early genes and octamer-containing cellular promoters in neuronal cells. Neuron (1990) 1.65
Activation of proto-oncogenes: an immediate early event in human cytomegalovirus infection. Science (1990) 1.63
Spontaneous reactivation of experimental herpes simplex keratitis in rabbits. Arch Ophthalmol (1967) 1.61
Reactivation of latent infection and induction of recurrent herpetic eye disease in mice. J Gen Virol (1990) 1.46
Epstein-Barr virus BZLF1 trans activator induces the promoter of a cellular cognate gene, c-fos. J Virol (1990) 1.41
Restricted expression of herpes simplex virus lytic genes during establishment of latent infection by thymidine kinase-negative mutant viruses. J Virol (1990) 1.35
Reactivation of murine latent HSV infection by epinephrine iontophoresis. Invest Ophthalmol Vis Sci (1984) 1.27
Lesion-induced increase in nerve growth factor mRNA is mediated by c-fos. Proc Natl Acad Sci U S A (1990) 1.24
Herpes simplex virus type I infection of the CNS induces major histocompatibility complex antigen expression on rat microglia. J Neurosci Res (1990) 1.14
Detection of HSV-1 proteins prior to the appearance of infectious virus in mouse trigeminal ganglia during reactivation of latent infection. Virus Res (1989) 0.85
mRNA levels of all three neurofilament proteins decline following nerve transection. Brain Res (1988) 0.84
Herpesviruses, latency and cancer: a biochemical approach. J Reticuloendothel Soc (1974) 0.84
Transcriptional induction of proto-oncogene fos by HSV-2. Biochem Biophys Res Commun (1987) 0.79
Detection of herpes simplex virus type 1 transcripts during latent infection in mice. J Virol (1987) 5.12
RNA from an immediate early region of the type 1 herpes simplex virus genome is present in the trigeminal ganglia of latently infected mice. Proc Natl Acad Sci U S A (1987) 4.98
Detection of HSV-1 genome in central nervous system of latently infected mice. Nature (1983) 3.95
Localization of herpes simplex virus in the trigeminal and olfactory systems of the mouse central nervous system during acute and latent infections by in situ hybridization. Lab Invest (1984) 3.67
Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infection. EMBO J (1989) 3.65
Retracted Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript. Nature (2006) 3.47
During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure. J Virol (1989) 3.29
Early Ad-2 transcription units: only promoter-proximal RNA continues to be made in the presence of DRB. Virology (1979) 3.06
Expression of herpes simplex virus type 1 latency-associated transcripts in the trigeminal ganglia of mice during acute infection and reactivation of latent infection. J Virol (1988) 2.80
In vivo and in vitro reactivation impairment of a herpes simplex virus type 1 latency-associated transcript variant in a rabbit eye model. J Virol (1991) 2.54
Latent herpes simplex virus type 1 transcripts in peripheral and central nervous system tissues of mice map to similar regions of the viral genome. J Virol (1988) 2.46
Herpes simplex type 1 DNA in human brain tissue. Proc Natl Acad Sci U S A (1981) 2.45
Mapping of low abundance latency-associated RNA in the trigeminal ganglia of mice latently infected with herpes simplex virus type 1. J Gen Virol (1990) 2.25
Mapping of RNA initiation sites by high doses of uv irradiation: evidence for three independent promoters within the left 11% of the Ad-2 genome. Virology (1979) 2.22
Physical state of the latent herpes simplex virus genome in a mouse model system: evidence suggesting an episomal state. Virology (1987) 2.05
The major late adenovirus type-2 transcription unit: termination is downstream from the last poly(A) site. J Mol Biol (1979) 2.04
Latent herpes simplex virus type 1 transcription in human trigeminal ganglia. J Virol (1988) 2.02
DRB-induced premature termination of late adenovirus transcription. Nature (1978) 1.98
Correlation between herpes simplex virus type 1 rate of reactivation from latent infection and the number of infected neurons in trigeminal ganglia. Virology (1996) 1.96
Multiple discrete sites for premature RNA chain termination late in adenovirus-2 infection: enhancement by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole. Proc Natl Acad Sci U S A (1979) 1.92
Latent herpes simplex virus type 1 DNA contains two copies of the virion DNA joint region. J Virol (1985) 1.90
Gene expression during reactivation of herpes simplex virus type 1 from latency in the peripheral nervous system is different from that during lytic infection of tissue cultures. J Virol (1997) 1.86
During lytic infection herpes simplex virus type 1 is associated with histones bearing modifications that correlate with active transcription. J Virol (2004) 1.84
A herpes simplex virus type 1 latency-associated transcript mutant reactivates with normal kinetics from latent infection. J Virol (1990) 1.83
In situ DNA PCR and RNA hybridization detection of herpes simplex virus sequences in trigeminal ganglia of latently infected mice. Virology (1995) 1.77
An HSV LAT null mutant reactivates slowly from latent infection and makes small plaques on CV-1 monolayers. Virology (1993) 1.69
Development of a syngenic murine B16 cell line-derived melanoma susceptible to destruction by neuroattenuated HSV-1. Mol Ther (2001) 1.47
Chromosomal organization of the herpes simplex virus genome during acute infection of the mouse central nervous system. J Virol (1986) 1.41
Tumor necrosis factor alpha transcription in macrophages is attenuated by an autocrine factor that preferentially induces NF-kappaB p50. Mol Cell Biol (1998) 1.41
Characterization of herpes simplex virus type 2 transcription during latent infection of mouse trigeminal ganglia. J Virol (1990) 1.34
The herpes simplex virus type 1 2.0-kilobase latency-associated transcript is a stable intron which branches at a guanosine. J Virol (1997) 1.33
Novobiocin and coumermycin A1 inhibit viral replication and the reactivation of herpes simplex virus type 1 from the trigeminal ganglia of latently infected mice. J Virol (1987) 1.23
A herpes simplex virus type 1 variant, deleted in the promoter region of the latency-associated transcripts, does not produce any detectable minor RNA species during latency in the mouse trigeminal ganglion. J Gen Virol (1990) 1.23
The replicating intermediates of herpes simplex virus type 1 DNA are relatively short. J Neurovirol (1995) 1.21
Herpesvirus vector gene transfer and expression of beta-glucuronidase in the central nervous system of MPS VII mice. Nat Genet (1992) 1.21
Investigation of herpes simplex virus type 1 (HSV-1) gene expression and DNA synthesis during the establishment of latent infection by an HSV-1 mutant, in1814, that does not replicate in mouse trigeminal ganglia. J Gen Virol (1991) 1.21
CpG frequency in large DNA segments. J Mol Evol (1983) 1.20
T1rho imaging of murine brain tumors at 4 T. Acad Radiol (2001) 1.17
Analysis of a herpes simplex virus type 1 LAT mutant with a deletion between the putative promoter and the 5' end of the 2.0-kilobase transcript. J Virol (1994) 1.17
The herpes simplex virus type 1 strain 17+ gamma 34.5 deletion mutant 1716 is avirulent in SCID mice. J Gen Virol (1994) 1.15
Egg proteins in cod serum. Natural occurrence and induction by injections of oestradiol 3-benzoate. Biochem J (1971) 1.15
A herpes simplex virus type 1 mutant with a deletion immediately upstream of the LAT locus establishes latency and reactivates from latently infected mice with normal kinetics. J Neurovirol (1996) 1.13
Herpes simplex virus type 1 latency-associated transcript (LAT) promoter deletion mutants can express a 2-kilobase transcript mapping to the LAT region. J Virol (1993) 1.11
The transcriptional activation domain of VP16 is required for efficient infection and establishment of latency by HSV-1 in the murine peripheral and central nervous systems. Virology (1999) 1.10
Latent herpes simplex virus type 1 DNA is not extensively methylated in vivo. J Gen Virol (1987) 1.08
An HSV-1 mutant lacking the LAT TATA element reactivates normally in explant cocultivation. Virology (1993) 1.07
Activation of BAG3 by Egr-1 in response to FGF-2 in neuroblastoma cells. Oncogene (2008) 1.07
Autocrine signals control CCAAT/enhancer binding protein beta expression, localization, and activity in macrophages. Blood (1998) 1.06
Herpes simplex virus type 1 mutant strain in1814 establishes a unique, slowly progressing infection in SCID mice. J Virol (1992) 1.05
Therapy of experimental human brain tumors using a neuroattenuated herpes simplex virus mutant. Lab Invest (1995) 1.05
Replication, establishment of latent infection, expression of the latency-associated transcripts and explant reactivation of herpes simplex virus type 1 gamma 34.5 mutants in a mouse eye model. J Gen Virol (1995) 1.04
Poly(A) sites of adenovirus serotype 2 transcription units. J Mol Biol (1982) 1.04
Incorporation of l-[C]leucine into egg proteins by liver slices from cod. Biochem J (1971) 1.02
The HSV-1 2-kb latency-associated transcript is found in the cytoplasm comigrating with ribosomal subunits during productive infection. Virology (1994) 1.02
A thymidine kinase-negative HSV-1 strain establishes a persistent infection in SCID mice that features uncontrolled peripheral replication but only marginal nervous system involvement. Virology (1994) 1.01
Gadusol, an enolic derivative of cyclohexane-1,3-dione present in the roes of cod and other marine fish. Isolation, properties and occurrence compared with ascorbic acid. Biochem J (1981) 1.00
Role of the immune response during neuro-attenuated herpes simplex virus-mediated tumor destruction in a murine intracranial melanoma model. Cancer Res (2000) 0.99
Herpes simplex virus type 1 gene expression and reactivation of latent infection in the central nervous system. Neuropathol Appl Neurobiol (1994) 0.99
Use of a "replication-restricted" herpes virus to treat experimental human malignant mesothelioma. Cancer Res (1997) 0.99
Treatment of experimental intracranial murine melanoma with a neuroattenuated herpes simplex virus 1 mutant. Virology (1995) 0.98
Long term herpes simplex virus type 1 infection of nerve growth factor-treated PC12 cells. J Gen Virol (1994) 0.98
N-linked oligosaccharides on herpes simplex virus glycoprotein gD are not essential for establishment of viral latency or reactivation in the mouse eye model. Virology (1994) 0.97
Analysis of protein expression from within the region encoding the 2.0-kilobase latency-associated transcript of herpes simplex virus type 1. J Virol (2001) 0.96
Identification of a novel 0.7-kb polyadenylated transcript in the LAT promoter region of HSV-1 that is strain specific and may contribute to virulence. Virology (1999) 0.95
Long-term AAV vector gene and protein expression in mouse brain from a small pan-cellular promoter is similar to neural cell promoters. Gene Ther (2009) 0.95
Repression of the HSV-1 latency-associated transcript (LAT) promoter by the early growth response (EGR) proteins: involvement of a binding site immediately downstream of the TATA box. J Neurovirol (1997) 0.94
Human corneal cells and other fibroblasts can stimulate the appearance of herpes simplex virus from quiescently infected PC12 cells. J Virol (1999) 0.94
The cellular response to herpes simplex virus type 1 (HSV-1) during latency and reactivation. J Neurovirol (2005) 0.94
Herpes simplex virus type 1 2-kilobase latency-associated transcript intron associates with ribosomal proteins and splicing factors. J Virol (2001) 0.93
Mapping of the 3' terminus of the large late ad-2 transcript by electron microscopy. Virology (1980) 0.93
Oral inoculation of SCID mice with an attenuated herpes simplex virus-1 strain causes persistent enteric nervous system infection and gastric ulcers without direct mucosal infection. Lab Invest (1995) 0.92
Transfectable and transplantable postmitotic human neurons: a potential "platform" for gene therapy of nervous system diseases. Exp Neurol (1997) 0.91
Oral-oesophageal inoculation of mice with herpes simplex virus type 1 causes latent infection of the vagal sensory ganglia (nodose ganglia). J Gen Virol (1994) 0.87
The HSV 1 genome in quiescently infected NGF differentiated PC12 cells can not be stimulated by HSV superinfection. J Neurovirol (2000) 0.87
Reactivation of herpes simplex virus from latently infected mice after administration of cadmium is mouse-strain-dependent. J Gen Virol (1996) 0.86
Therapy of a murine model of pediatric brain tumors using a herpes simplex virus type-1 ICP34.5 mutant and demonstration of viral replication within the CNS. J Neuropathol Exp Neurol (1996) 0.86
Stable levels of long-term transgene expression driven by the latency-associated transcript promoter in a herpes simplex virus type 1 vector. Mol Ther (2005) 0.85
A mouse model for varicella-zoster virus latency. Microb Pathog (1993) 0.85
Effect of oestradiol 3-benzoate on the biosynthesis of egg proteins by cod. Biochem J (1970) 0.85
Detection of HSV-1 proteins prior to the appearance of infectious virus in mouse trigeminal ganglia during reactivation of latent infection. Virus Res (1989) 0.85
Nucleotide sequences from HeLa cell HnRNA. FEBS Lett (1973) 0.84
A neuroattenuated ICP34.5-deficient herpes simplex virus type 1 replicates in ependymal cells of the murine central nervous system. J Gen Virol (1998) 0.84
The HSV-1 latency associated transcript (LAT) variants 1704 and 1705 are glycoprotein C negative. Virus Res (1991) 0.84
A herpes simplex virus type 1 mutant lacking the ICP0 introns reactivates with normal efficiency. J Virol (1991) 0.83
The transcription termination region of the adenovirus 2 major late transcript contains multiple functional elements. J Gen Virol (1989) 0.83
Treatment of experimental subcutaneous human melanoma with a replication-restricted herpes simplex virus mutant. J Invest Dermatol (1997) 0.82